The market cap is now reported as $39 million for PTN. It should be true to my knowledge that this is less than the cash held by PTN. I do not think there is debt. Please correct me if I am wrong about those things. Thanks.

If the lawsuit is successful does the $16 million go to CATV or to MF?

Do the Grow Pods have any chance of having successful sales?

Is there any other product that could have successful sales? Perhaps the Delta 8 Hip Water?

Is it criminal fraud regarding the fact that the tangible assets were never owned by the shareholders? My understanding is that the shareholders paid $10 million for CIGN but received nothing that had any real value in return. Was this properly disclosed to shareholders?

Is there going to be a shareholder lawsuit against MF for fraud?

There are lawyers usually looking for these types of cases.

Thanks

The market cap is $60 million. I think I saw recently that PTN has $60 million left from what AMAG gave to PTN to drop Vyleesi.

A valuation of a company at cash on hand should be some sort of floor fundamentally.

In the short term stocks are a popularity contest. Reverse stock splits are unpopular. In the long term stock valuation is a weighing process.

The DED treatment could actually work.

Vyleesi is FDA approved and works better in men than in women. Women are not a good market for an aphrodisiac but men would be a strong market.

It is hard I understand however to believe in a company that has never delivered for its shareholders in the past.

The market cap is $2.1 million. The company owns greenhouses and other assets. Is there a “book value” that can be compared to the market cap?

IHUB financials shows - 1.4 billion share float. (negative 1.4 billion) The outstanding shares are 3+ billion shares. Does this mean that in actual fact there are billions of shares held short in CATV?

If the CE were to lift could there be a massive short squeeze?

Thanks

That is good to hear. I am curious about how the Amanita Muscaria mushrooms are harvested. I read that they are foraging for them in the wild rather than growing the mushrooms in a grow room.

Is it necessary to grow them in the wild or could they be farmed in a grow room?

A poster here has been warning us about the toxic convertible debt here with WHSI. And how that ruins the chances of shareholders doing well.

Can we still get a run up in PPS if the product roll out does happen and Kathy Ireland actually is promoting the product prominently in the media?

It appears that the product (Health MONITOR) will not be sold in large chain drug stores. Is that true? Will the product be sold on Amazon?

Will NVIV do a dilutive offering before or after the INSPIRE 2 results get announced? If before then it might be better to wait and buy after dilution. If before then that would be better for current shareholders.

INSPIRE 1 was a success. That would mean that INSPIRE 2 is probably a success. I am concerned about having the IP rights expire in a short period of time.

Thanks Blue Skies. The focus has shifted for AXIM to the DED tests which could be a good market I believe. However I still see the Covid-19 neutralizing antibody tests as a much larger potential market.

With the BA 5 variant of Covid 19 prevailing recently, could AXIM develop a new lateral flow test for antibodies tailored to this new prevailing variant? Might the FDA change their mind at some point and allow for these tests to be sold to the public as well as research institutions?

I never did see the great harm in letting people know something important about themselves.

Since Dr. Otiko has hundreds of millions of shares it seems to me that he would also want VDRM to succeed if that were at all possible.

Communicating well with shareholders might be perilous for him since there could be legal entanglements if he were to say the wrong thing or promise too much perhaps.

Did VDRM file the proper extension now that was missed a few days ago due to Dr. O being out of the country. What was the reason to leave the country?

Does IR respond to people other than Slops?

How much money does AXIM need to raise to get the DED testing kits selling? Perhaps just to sell a few tests to get a feel for the demand that exists.

Does CATV have the financial resources to start the lawsuit against OTCM?

How could they sell shares to raise money if CATV is still under CE status?

The CE did destroy a substantial market cap. Are the damages claimed the difference between the market cap before the CE and the market cap now + penalties?

What court has the jurisdiction over the OTCM?

Perhaps the lawyers could take this case on a contingency fee basis.

Analysts had a price target of around $3.00. Does that target now get automatically updated to $75?

I tried to order Calm at the store. The functions worked very well until I got to the payment step. That is where the malfunction happened for me. Perhaps the company should address this issue.

Vyleesi aka PTN-141 aka bremelanotide is in fact an effective aphrodisiac. Somehow this fact just got buried. This is counterintuitive. The drug works, but the company failed to market the drug effectively.

The DED treatment uses a novel mechanism of action. It could be more effective than the SOC. Phase 3 with finish fairly soon.

Informing the shareholder is not a high priority with the PTN management. Vyleesi could get discovered by women and shared with husbands and other partners. Men benefit even more than do women on average. This never gets discussed. Why should men be denied?

Thanks for the news of 10,000 units. How did you learn of this?

I called IR and left a message about what is the status of the new stain free VitaStem. Would he be allowed to tell me any information about manufacturing status or inventory or delivery to Amazon?

Does it mean that AXIM is likely a scam because BLSQ was promoting the business prospects here?

What is the special appeal of delta 8? Normal THC is delta 9 I think. CBD is a different cannabinoid. Is delta 8 intoxicating like THC delta 9? Or is it therapeutic but not intoxicating like CBD is? Thanks

If we could see that the stain free VitaStem is being manufactured as promised it would alleviate some doubt here.

Do we have the necessary money to pay the manufacturer?

The market cap is $12 million. If we actually have sales this year of DED tests to ophthalmologists and optometrists and there is a real need for these tests then the valuation could be too low. Janey thinks this is a scam. I see it more as unfortunate the way the NAB test never got used by the public.

What sort of yearly revenues could we hope for from DED? It is a simple test to do in the clinic but there is some question on whether the FDA would require a certified laboratory to do the tests. This uncertainty needs to be cleared up.

Over on Stock Twits a person posted that IKBR is allowing purchase of CATV. I just called and they said no this is not true. The guy even showed a screen shot of his purchase. This whole thing seems odd. The stock price is 0.0008. I would purchase if I could purchase. It trades on the grey market. Is it only Canadians that have an access to the grey market?

No trades today so far. Could we be halted? If the CE were to come off at what time of day would that information be broadcast?

Should Michael Feldenkrais , our CEO , be communicating with his shareholders or is going dark a ominous sign of the future outcome for CATV?

Did the greenhouse roof get repaired? Is the Hip Bistro doing a good business? Perhaps a posted menu from the Hip Bistro would interesting to see.

Buying into the DED business at 5 cents per share might be an opportunity. What does the squirrel think at this juncture?

Inspire 1 and Inspire 2 have taken a long time to complete. We are at 19 of 20 patients in Inspire 2. The patents to protect our intellectual property must now have a limited time left until expiration. Perhaps the new addition of stem cells and nerve growth factors in future trials would extend patent protection for a much longer time. Are we filling for new patents?

I remember seeing a post from Dr. Otiko that the stain free VitaStem product will be available in a few weeks. However that might have been 6 weeks a go or so.

Is there a limitation due to Fair Disclosure requirements for Dr. Otiko to tell investors what is causing a delay?

What is the company’s name in North Carolina that is manufacturing the stain free VitaStem? Are we able to pay them the required money for producing the product?

What sort of price target are investors and speculators putting on WHSI. At 4 cents there was a sudden sell off. I wish I had decided to sell at 0.04. Other posters have said $1.00 is a possibility. We have suffered dilution recently. That would mean everybody would need to lower their price target for WHSI.

When do we get to see the Kathy Ireland promotions for WHSI health protection products?

Is there no scientific credibility for the 4 DED tests and the testing accuracy? Why is it specifically that this would be known to be a scam? I think there is a need for accurate testing for DED. It is not always an easy disease to diagnose. Paradoxically many patients experience excessive tearing.

I agree however that the price performance of the stock is consistent with how a scam stock would perform if investors thought it was a scam.

I see 2 trades for 10,000 shares at 0.0001. Is that worth $2.00?

Do we know who is manufacturing the stain free VitaStem?

The Market Cap is around $9 million. What sort of annual DED test sales could be in the ballpark for AXIM? If sales were growing rapidly what sort of pps could be justified? Thanks

It is a product that works. It is a product that people want. The issue seems to be logistics. Dr. Otiko is doing this whole thing by himself it seems.

Did the quarterly financial report released today cause any new concerns or reasons for optimism? It could be a profitable company with an actual execution of the business plan.

Now the market cap is $4.9 million. If Inspire 2.0 is a success that would be worth how much. After this comes stem cells and nerve growth factors in addition to the Spinal scaffold implant.

I think we have enough cash to finish the Inspire 2.0.

We have more cash on hand than the market cap of the company. Does that mean that our intellectual property is worth nothing or less than nothing?

Who is it that has the authority to make the CE removal decision? What sort of documentation must be properly presented? Are we linked specifically to the Svorai case proceedings?

Specifically it is the stain free tetracycline product that penetrates the dermal layers better than competitor products do that could see a sizable market demand.

A lot of people saw what happened in Jan and Feb of 2021. Was that 30x in one month? How often does that happen? Selling at that relatively brief momentary crest is the key skill to have.

I do not yet have that quick timely selling talent. Also you can almost always buy it back again later for cheaper if you want to stay with the stock.

There is Amazon resupply, hospital contracts, state by state revenues. There were other products to launch.

Is there a future date to look out for when the CE decision could be considered with adequate established information?

I am amazed that LPCN is now 0.92. Testosterone replacement therapy is a large market. Will sales disappoint for a reason?

Is Vyleesi a product potentially delivered in a patch. Are there countries where men can use Vyleesi?

SAVA is working on a test to detect early onset Alzheimer’s before it is debilitating. If there is also a treatment to prevent Alzheimer’s this would be a wonderful combination of products.

If there were no effective treatment for Alzheimer’s then a reliable positive test would be a lifestyle choice worse than having no such knowledge since no knowledge would be a relatively more blissful state of mind.

Absolutely great post MallenNV. Since this is all legal, there could be schools charging a tuition to teach new young scammers how to do the exact same highly profitable scam you delineate.

Your book will be a great one. I want to order a copy for myself. It has been fun to follow SGMD and your commentary and how you profited from being short.

My question still is how it is that you went short without the sort of very high margin requirement that a brokerage house establishes. This margin seems to reflect a massive risk in being short if there would be a spike up in price. This protects the brokerage from any losses.

Thanks again.

The market cap is $7 million. If Inspire 2 gets fully enrolled and is successful what would be the market cap? The company has two or three times the market cap in cash. One year or so of cash burn runway.

Why are the CEO salaries so high?